Molecular diagnostics technology aids management of E. coli crisis
14 June, 2011A new xTAG gastrointestinal pathogen panel has been used to triage patients suspected of having an E. coli infection at German Kliniken der Stadt Koln.
Experimental vaccine protects against Hendra virus
18 May, 2011Trials by the CSIRO have shown that an experimental vaccine can protect horses against the deadly Hendra virus. Stopping the disease in horses could also help protect people from the disease.
The chemistry of sex and mosquito-borne disease
22 March, 2011A female mosquito’s tendencies to feed, produce eggs and mate can be permanently altered by more than 100 proteins in male sperm. Now researchers are suggesting that ways to control diseases such as West Nile virus and dengue fever could be uncovered by investigating the intricacies of the sex lives of mosquitoes.
CSIRO part of global battle against pandemic threats
17 February, 2011CSIRO joins the global battle against bird flu and other mutating viruses.
New research in early lung cancer detection
09 February, 2011Researchers are now working to develop a new diagnostics platform with which lung cancer can be diagnosed in its early stages, even during a visit to the general practitioner.
New ISO standard helps find out how toxic nanoparticles are
08 February, 2011With the rapid growth of nanotechnology-based products, researchers, manufacturers, regulators and consumers are increasingly concerned with their safety and environmental impact. To help address this issue, ISO has published an International Standard to support the inhalation toxicity testing of nanoparticles.
Scientists find drugs can cause sudden cardiac death
01 February, 2011Australian researchers have come one step closer to understanding how the rhythm of the heartbeat is controlled and why many common drugs, including some antibiotics, antihistamines and anti-psychotics, can cause a potentially fatal abnormal heart rhythm.
Genetic test predicts IVF success
17 January, 2011It has been found that different subtypes of the FMR1 gene (also known as the fragile X mental retardation gene) in potential mothers are associated with significantly different chances of conceiving with in vitro fertilisation (IVF). Now researchers have developed a genetic blood test that predicts the chances that IVF will lead to a successful pregnancy.
Discovery agreement signed in the field of autoimmune disease
17 January, 2011Ono Pharmaceutical Co (Osaka, Japan) and BioFocus (Saffron Walden, UK) have signed a collaboration agreement, focused on discovering novel targets in the field of autoimmune disease.
Diagnostic tool predicts bronchiolitis obliterans syndrome
13 January, 2011A lung transplant can mean a new chance at life. But many who receive one develop a debilitating, fatal condition that causes scar tissue to build up in the lungs and chokes off the ability to breathe.
Centre targets epidemic battles
03 November, 2010The early identification of biomarkers to aid in the fight against diabetes, depression and other epidemic diseases will be the focus of a new Australian-German centre launched at The Australian National University.
Researchers find a 'liberal gene'
03 November, 2010Liberals may owe their political outlook partly to their genetic make-up, according to new research from the University of California, San Diego, and Harvard University.
Lab tests point to better outcome for human blood cancers
26 October, 2010The treatment of a range of human blood cancers, such as chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia, may be improved as a result of international research involving The University of Western Australia.
Strictly Ballroom finds brain's colour centre
20 October, 2010In a discovery that challenges the scientific theory that colour processing is split across different parts of the human brain, researchers have used the movie Strictly Ballroom to locate the region in human brains.
Bioo Scientific MaxDiscovery AST and LDH colour endpoint assay kits
07 October, 2010 byBioo Scientific’s MaxDiscovery Aspartate Transaminase (AST) and Lactate Dehydrogenase (LDH) colour endpoint assays use a proprietary technology for visible detection of in vivo toxicity using only 5 µL of serum from rodents or other mammals. These assays are powerful tools for the detection of drug-induced toxicity to the liver and heart and can be used for preclinical testing in the drug discovery process.
